PROGRAM DRUG DEVELOPMENT MEETING MARCH 22-23, 2018
Day 1
830 Welcome – A/Prof Anthony Joshua
835 Opening Address – Dr David Currow
Session 1 - Phase 1 The Next Generation - Moderator - Dr Lisa Horvath (Lifehouse)
845 -930 Prof Johann De Bono – Where next in Phase 1?
930-945 Discussion
945-1015 A/Prof David Ziegler – What’s new in Paediatric phase 1? The national WGS, RNA-Seq, avatar effort in paediatric tumours
1015-1030 Discussion
1030-11 A/Prof Catriona McNeil – NSW Perspectives on Phase 1 – A view from the coal-face
11-1130 Morning Tea
1130-12 Prof Jayesh Desai – VCCC – Pushing the Boundaries in Phase 1 Trials
12-1230 Dr Alex Menzies - Integrating research into Early phase trials in Melanoma
1230-1 Prof Sabe Sabesan - Clinical trial access to rural, regional and rare cancer patients using telehealth
1-2 Lunch
Session 2 – Immuno-Oncology Looking over the Horizon - Moderator - Dr Charlotte Lemech (Scientia)
2-245 Prof Thomas Gajewski – The Next Generation of Immuno-Oncology
245-3 Discussion
3-330 Prof Chris Goodnow – Germline influences on Responses to Immuno-Oncology
330-4 Afternoon Tea and Posters
4-430 Prof Kerrie MacDonald – Immuno-Oncology in GBM
430-5 Prof Philip Darcy – CAR-T cell therapies in Cancer
5-530 Prof David Thomas - Genomics and Immuno-Genomics in Early Phase Trials
630 Faculty Dinner
Day 2 Pipeline Presentations from Pharma (Indicative Only) - Moderator - Dr Amy Prawira (TKCC)
830-9 Macrogenics
9-930 MSD
930-10 BMS
10-1030 Morning Tea
1030-11 AstraZeneca/ MedImmune
11-1130 Amgen
1130-1230 Lunch
1230-1 Janssen
1-130 Roche/Genentech
130-2 Novartis
PROGRAM DRUG DEVELOPMENT MEETING MARCH 22-23, 2018
Day 1
830 Welcome – A/Prof Anthony Joshua
835 Opening Address – Dr David Currow
Session 1 - Phase 1 The Next Generation - Moderator - Dr Lisa Horvath (Lifehouse)
845 -930 Prof Johann De Bono – Where next in Phase 1?
930-945 Discussion
945-1015 A/Prof David Ziegler – What’s new in Paediatric phase 1? The national WGS, RNA-Seq, avatar effort in paediatric tumours
1015-1030 Discussion
1030-11 A/Prof Catriona McNeil – NSW Perspectives on Phase 1 – A view from the coal-face
11-1130 Morning Tea
1130-12 Prof Jayesh Desai – VCCC – Pushing the Boundaries in Phase 1 Trials
12-1230 Dr Alex Menzies - Integrating research into Early phase trials in Melanoma
1230-1 Prof Sabe Sabesan - Clinical trial access to rural, regional and rare cancer patients using telehealth
1-2 Lunch
Session 2 – Immuno-Oncology Looking over the Horizon - Moderator - Dr Charlotte Lemech (Scientia)
2-245 Prof Thomas Gajewski – The Next Generation of Immuno-Oncology
245-3 Discussion
3-330 Prof Chris Goodnow – Germline influences on Responses to Immuno-Oncology
330-4 Afternoon Tea and Posters
4-430 Prof Kerrie MacDonald – Immuno-Oncology in GBM
430-5 Prof Philip Darcy – CAR-T cell therapies in Cancer
5-530 Prof David Thomas - Genomics and Immuno-Genomics in Early Phase Trials
630 Faculty Dinner
Day 2 Pipeline Presentations from Pharma (Indicative Only) - Moderator - Dr Amy Prawira (TKCC)
830-9 Macrogenics
9-930 MSD
930-10 BMS
10-1030 Morning Tea
1030-11 AstraZeneca/ MedImmune
11-1130 Amgen
1130-1230 Lunch
1230-1 Janssen
1-130 Roche/Genentech
130-2 Novartis